Article
[Molecular imaging for drug development].
Brain and nerve = Shinkei kenkyu no shinpo - 1 Mar 2007
Watanabe Yasuyoshi
Abstract excerpt
In vivo molecular imaging has become a key technology for drug development and pathophysiological science. We are mostly utilizing PET (positron emission tomography) as a first-choice modality, because of its ultra-high sensitivity for molecules, adequate temporal and spatial resolution, and especially broad spectrum of target molecules. The present status for development of PET molecular probes, instrumentations...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
